Lymphokine‐activated killer cell activity in patients with primary and metastatic malignant liver tumors
Roderich E. Schwarz, Shunzaburo Iwatsuki, Ronald B. Herberman, Theresa L. Whiteside – 1 August 1989 – Lymphokine‐activated killer cells were generated from peripheral blood mononuclear cells of 33 patients with liver tumors (benign, 6; primary malignant, 10; metastatic, 17) and 10 healthy individuals. Although peripheral blood mononuclear cell yield was significantly lower (p < 0.01) in patients with hepatocellular carcinoma or with metastatic colorectal cancer, natural killer activity in the peripheral blood mononuclear cell fraction was comparable in all groups tested.